• No results found

CYP2C9*2 and *3

Polymorphisms of CYP2C9*2, CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fibrillation using warfarin

<p>Polymorphisms of <em>CYP2C9*2</em>, <em>CYP2C9*3</em> and <em>VKORC1</em> genes related to time in therapeutic range in patients with atrial fibrillation using warfarin</p>

... probe CYP2C9*2 (rs1799853) assay (C__25625805_10), CYP2C9*3 (rs1057910) assay (C_27104892_10) and VKORC1 -1639G>A (rs9923231) assay ...

9

CYP2C9 ) and response ( VKORC1 ) have an

CYP2C9 ) and response ( VKORC1 ) have an

... least 3 months with a target INR range of ...within 2 weeks prior to study enrolment, and ...The CYP2C9*2 and *3 allelic frequencies were ...homozygous CYP2C9*3 carrier in ...

315

The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes on the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy

<p>The Effect of CYP2C9 Genotype Variants in Type 2 Diabetes on the Pharmacological Effectiveness of Sulfonylureas, Diabetic Retinopathy, and Nephropathy</p>

... alleles CYP2C9*2 and *3 were genotyped by PCR – restric- tion fragment length polymorphism ...90mL/min/1.73m 2 (G1) was considered as normal or high GFR, while GFR ≤ 15 (G5) was described as ...

8

Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy

Identification of CYP2C9 and VKORC1 polymorphisms in Iranian patients who are under warfarin therapy

... / CYP2C9 polymorphisms and warfarin sensitivity and severe side effects in Iranian ...of CYP2C9*2, CYP2C9*3 and VKORC1 allelic variants in this study makes it difficult to assume a ...

8

Investigating the role of plasma glucose concentration as a phenotypic marker for CYP2C9 genetic variants, in the diabetic population of Gujarat

Investigating the role of plasma glucose concentration as a phenotypic marker for CYP2C9 genetic variants, in the diabetic population of Gujarat

... of CYP2C9 genetic variants in Gujarat state diabetic ...for CYP2C9*2 and CYP2C9*3 ...of CYP2C9*1, CYP2C9*2 and CYP2C9*3 alleles in the Gujarat state ...

6

CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment

CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment

... enzymes CYP2C9 and CYP2C19; 90% of this metabolization is done by CYP2C9 and the remaining 10% by ...of CYP2C9 may reduce the metabolism of PHT by 25–50% in patients with variants *2 and ...

8

Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus

Effect of CYP2C9 polymorphisms on prescribed dose and time-to-stable dose of sulfonylureas in primary care patients with Type 2 diabetes mellitus

... The primary end point of our study was the effect of the CYP2C9*2 and CYP2C9*3 alleles on the stable SU dose. This was defined as the first period of 270 consecutive days or more without SU ...

7

Genetic Polymorphisms of CYP2C9: Comparison of Prevalence in the Lebanese Population with Other Populations

Genetic Polymorphisms of CYP2C9: Comparison of Prevalence in the Lebanese Population with Other Populations

... the CYP2C9*2,*3,*4, and *5 alleles was performed by means of PCR (MyCy- cler; BioRad laboratories, Hercules, Calif) followed by Pyrosequencing [8] by using PSQ HS 96A System (Bio- tage AB), with use ...

6

Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy

Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy

... of CYP2C9*1/*2/*3 alleles were ...polymorphism. CYP2C9*2 genotyping showed 91 % to be wild (CC) and 9 % were heterozygous ...(Table 2). Genotyping for CYP2C9*3 ...

7

Vol 8, No 4 (2016)

Vol 8, No 4 (2016)

... both CYP2C9*2 and VKORC1-1639G>A, that means having neither heterozygous nor homozygous mutant genotypes of the tow genes ...type CYP2C9*1*1 genotype being ...

12

Efficacy of piroxicam for postoperative pain after lower third molar surgery associated with CYP2C8*3 and CYP2C9

Efficacy of piroxicam for postoperative pain after lower third molar surgery associated with <em>CYP2C8*3</em> and <em>CYP2C9</em>

... CYP2C8*3, CYP2C9*2 and CYP2C9*3 with the clinical efficacy of oral piroxicam (20 mg daily for 4 days) after invasive lower third molar surgeries with regard to pain, swelling, trismus, ...

9

Download
			
			
				Download PDF

Download Download PDF

... i CYP2C9 utječe na bioraspoloživost i kliničke ishode liječenja ibuprofenom i diklofenakom, koji se svrstavaju među najčešće propisivane nesteroidne protuupalne ...i CYP2C9*2*3 na ...

8

CYP2C9 Polymorphism and Unstable Anticoagulation with Warfarin in Patients Within the First 3 Months Following Heart Valve Replacement

CYP2C9 Polymorphism and Unstable Anticoagulation with Warfarin in Patients Within the First 3 Months Following Heart Valve Replacement

... the CYP2C9 gene had lower both estimated and actual warfarin doses than pa- tients with the CYP2C9*1/*1 ...of CYP2C9*2 and/or CYP2C9*3 gen- otypes required a lower maintenance ...

8

Cytochrome P450 genetic variants and hypertension risk in South Indian population

Cytochrome P450 genetic variants and hypertension risk in South Indian population

... , CYP2C9*2 , CYP2C9*3 polymorphisms, and HTN compared between cases and healthy controls are shown in Table ...The CYP2C9*2 CT + TT genotype between the cases and the controls ...

5

2 (3 Chloro­phen­yl) 4 (2 hy­droxy­ethyl) 3 methyl­morpholin 2 ol monohydrate

2 (3 Chloro­phen­yl) 4 (2 hy­droxy­ethyl) 3 methyl­morpholin 2 ol monohydrate

... C9 0.012 (2) 0.042 (4) 0.030 (3) 0.002 (2) 0.011 (2) 0.006 (3) C10 0.018 (2) 0.029 (3) 0.028 (3) 0.000 (2) 0.008 (2) 0.000 (2) C11 0.018 ...

7

(Z) 2 Thio­phen 3 yl­methyl­ene 1 aza bi­cyclo­[2 2 2]­octan 3 one

(Z) 2 Thio­phen 3 yl­methyl­ene 1 aza bi­cyclo­[2 2 2]­octan 3 one

... Fig. 1 shows an ellipsoid plot of (I) and selected geometrical parameters are presented in Table 1. In the title molecule, the C3ÐC6 bond is in a trans disposition with respect to the C7Ð C14 bond. The double bond is ...

7

Methyl 3 (2 chloro 5 ethyl 3 pyrid­yl) 3 hydr­­oxy 2 methyl­ene­propanoate

Methyl 3 (2 chloro 5 ethyl 3 pyrid­yl) 3 hydr­­oxy 2 methyl­ene­propanoate

... The Baylis–Hillman (Baylis & Hillman, 1972) (BH) reaction and related processes have become increasingly important for synthetic organic chemists, because the resulting adducts with a variety of functional groups and ...

7

N (3 Chloro­phen­yl) 2 cyano 3 (4 hydr­­oxy 3 meth­­oxy 2 nitro­phen­yl)prop 2 enamide

N (3 Chloro­phen­yl) 2 cyano 3 (4 hydr­­oxy 3 meth­­oxy 2 nitro­phen­yl)prop 2 enamide

... We are very grateful to the National Natural and Scientific Foundation (grant No. 20272053). We also acknowledge financial support from the Science and Technology Bureau of Zhejiang Province (grant No. 2005 C23022). The ...

7

(Z) 3 Chloro N [(Z) 3 (3 chloro 2 methyl­phenyl­imino)­butan 2 yl­­idene] 2 methyl­aniline

(Z) 3 Chloro N [(Z) 3 (3 chloro 2 methyl­phenyl­imino)­butan 2 yl­­idene] 2 methyl­aniline

... There is a considerable interest in the development of new late transition metal catalysts for the polymerization of α - olefins since Brookhart discovered highly active α -diimine nickel catalysts (Johnson et al. , ...

5

N′ (3 Eth­­oxy 2 hy­droxy­benzyl­­idene) 3 hy­droxy­naphthalene 2 carbohydrazide

N′ (3 Eth­­oxy 2 hy­droxy­benzyl­­idene) 3 hy­droxy­naphthalene 2 carbohydrazide

... In the structure of (I) (Fig. 1), the naphthyl ring and 2-hydroxyphenyl methylidene hydrazide moiety are nearly coplanar with the dihedral angle between the phenyl ring and the naphthyl ring is 8.5 (2) °; ...

7

Show all 10000 documents...

Related subjects